{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:38:23Z","timestamp":1790667503485,"version":"4.1.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Hepatitis E virus (HEV) is a common cause of viral hepatitis in developing countries, most commonly transmitted through the fecal-oral route. The virus is mainly of genotypes (GT) 1 and GT2 genotypes, and patients usually show symptoms of acute hepatitis. Due to the rising trend of HEV serological prevalence in global population, HEV has become an important public health problem in developed countries. Severe hepatitis caused by HEV includes acute and chronic liver failure (ACLF). ACLF frequently occurs in developed countries and is caused by overlapping chronic liver diseases of HEV with genotypes GT3 and GT4. Because the onset of hepatitis E is closely associated with immunity, it is critical to understand the immunological mechanism of hepatitis E associated with acute and chronic liver failure (HEV-ACLF). This review discusses the immunological manifestations and mechanisms of HEV-ACLF, intrahepatic immune microenvironment and treatment, and raises outstanding questions about the immunological mechanism and treatment of the disease.<\/jats:p>","DOI":"10.3389\/fmed.2021.725993","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T05:28:48Z","timestamp":1628486928000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Immunological Manifestations of Hepatitis E-Associated Acute and Chronic Liver Failure and Its Regulatory Mechanisms"],"prefix":"10.3389","volume":"8","author":[{"given":"Jian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naizhou","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2893.2010.01338.x","article-title":"Study of cellular immune response against Hepatitis E virus (HEV)","volume":"18","author":"Prabhu","year":"2011","journal-title":"J Viral Hepat."},{"key":"B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.clinbiochem.2018.11.012","article-title":"NLR and RLR in predicting liver failure and prognosis in patients with hepatitis E virus infection","volume":"63","author":"Wu","year":"2019","journal-title":"Clin Biochem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.7326\/0003-4819-150-6-200903170-00026","article-title":"Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab","volume":"150","author":"Ollier","year":"2009","journal-title":"Ann Intern Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1056\/NEJMc0903778","article-title":"Persistent carriage of hepatitis E virus in patients with HIV infection","volume":"361","author":"Dalton","year":"2009","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1128\/CMR.00062-13","article-title":"Host immune status and response to hepatitis E virus infection","volume":"27","author":"Krain","year":"2014","journal-title":"Clin Microbiol Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/jvh.13344","article-title":"Altered faecal microbiota on the expression of Th cells responses in the exacerbation of patients with hepatitis E infection","volume":"27","author":"Wu","year":"2020","journal-title":"J Viral Hepat."},{"key":"B8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/gutjnl-2011-300708","article-title":"Chronic hepatitis E infection in children with liver transplantation","volume":"61","author":"Halac","year":"2012","journal-title":"Gut."},{"key":"B9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jceh.2017.08.006","article-title":"A case of acute-on-chronic liver failure (ACLF) due to an uncommon acute and chronic event","volume":"8","author":"Agrawal","year":"2018","journal-title":"J Clin Exp Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jceh.2013.08.013","article-title":"Hepatitis E and acute-on-chronic liver failure","volume":"3","author":"Kumar","year":"2013","journal-title":"J Clin Exp Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.gtc.2020.01.011","article-title":"Hepatitis E: epidemiology, clinical course, prevention, and treatment","volume":"49","author":"Goel","year":"2020","journal-title":"Gastroenterol Clin North Am."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6027361","DOI":"10.1155\/2020\/6027361","article-title":"Th1\/Th2 cells and associated cytokines in acute hepatitis E and related acute liver failure","volume":"2020","author":"Wu","year":"2020","journal-title":"J Immunol Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.hbpd.2019.07.003","article-title":"The immunological roles in acute-on-chronic liver failure: an update","volume":"18","author":"Chen","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1055\/s-0038-1672201","article-title":"Acute on chronic liver failure and immune dysfunction: a mimic of sepsis","volume":"39","author":"Hensley","year":"2018","journal-title":"Semin Respir Crit Care Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/1743-422X-7-213","article-title":"Dynamics of HEV viremia, fecal shedding and its relationship with transaminases and antibody response in patients with sporadic acute hepatitis E","volume":"7","author":"Chandra","year":"2010","journal-title":"Virol J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0016-5085(95)90028-4","article-title":"Protracted viremia during acute sporadic hepatitis E virus infection","volume":"108","author":"Nanda","year":"1995","journal-title":"Gastroenterology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1365-2893.2008.01036.x","article-title":"Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E","volume":"15","author":"Srivastava","year":"2008","journal-title":"J Viral Hepat."},{"key":"B18","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/jmv.20617","article-title":"Locally acquired hepatitis E virus infection, El Paso, Texas","volume":"78","author":"Amon","year":"2006","journal-title":"J Med Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.hepres.2005.01.008","article-title":"Acute hepatitis E of a man who consumed wild boar meat prior to the onset of illness in Nagasaki, Japan","volume":"31","author":"Masuda","year":"2005","journal-title":"Hepatol Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/(SICI)1096-9071(199903)57:3<243::AID-JMV6>3.0.CO;2-R","article-title":"Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV","volume":"57","author":"Schlauder","year":"1999","journal-title":"J Med Virol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1440-1746.2010.06356.x","article-title":"Adaptive immune responses during acute uncomplicated and fulminant hepatitis E","volume":"26","author":"Srivastava","year":"2011","journal-title":"J Gastroenterol Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4103\/0255-0857.108725","article-title":"Evaluation of antigenicity and cell mediated immunity of hepatitis E virus patients: using non-radioactive MTT assay","volume":"31","author":"Majumdar","year":"2013","journal-title":"Indian J Med Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1440-1746.2007.04913.x","article-title":"Hepatitis E virus infection and fulminant hepatic failure during pregnancy","volume":"22","author":"Jilani","year":"2007","journal-title":"J Gastroenterol Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jhep.2007.05.014","article-title":"Soluble CD163 from activated macrophages predicts mortality in acute liver failure","volume":"47","author":"Moller","year":"2007","journal-title":"J Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00430-014-0338-1","article-title":"Increased expressions of NKp44, NKp46 on NK\/NKT-like cells are associated with impaired cytolytic function in self-limiting hepatitis E infection","volume":"203","author":"Das","year":"2014","journal-title":"Med Microbiol Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1053\/gast.2000.9364","article-title":"Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure","volume":"119","author":"Streetz","year":"2000","journal-title":"Gastroenterology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2249.1996.d01-783.x","article-title":"Metabolic disturbance and sensitivity to endotoxin in patients with advanced cancer: relationship to lymphocyte reactivity, tumour necrosis factor (TNF) production and survival","volume":"105","author":"Gough","year":"1996","journal-title":"Clin Exp Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1084\/jem.20051044","article-title":"IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508","volume":"202","author":"Hwang","year":"2005","journal-title":"J Exp Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1009367","DOI":"10.1371\/journal.ppat.1009367","article-title":"Effector memory CD8 T cell response elicits Hepatitis E Virus genotype 3 pathogenesis in the elderly","volume":"17","author":"El Costa","year":"2021","journal-title":"PLoS Pathog."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/0092-8674(91)90279-8","article-title":"Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity","volume":"67","author":"Butcher","year":"1991","journal-title":"Cell."},{"key":"B31","doi-asserted-by":"publisher","first-page":"8032","DOI":"10.3748\/wjg.v21.i26.8032","article-title":"Changes in gene expression in liver tissue from patients with fulminant hepatitis E","volume":"21","author":"Naik","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.3748\/wjg.v16.i15.1811","article-title":"Role of monocytes and macrophages in experimental and human acute liver failure","volume":"16","author":"Possamai","year":"2010","journal-title":"World J Gastroenterol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1189\/jlb.0308173","article-title":"Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury","volume":"84","author":"Holt","year":"2008","journal-title":"J Leukoc Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jss.2012.11.051","article-title":"Role of Kupffer cells and toll-like receptor 4 in acetaminophen-induced acute liver failure","volume":"180","author":"Fisher","year":"2013","journal-title":"J Surg Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fphys.2012.00056","article-title":"Functional role of monocytes and macrophages for the inflammatory response in acute liver injury","volume":"3","author":"Zimmermann","year":"2012","journal-title":"Front Physiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nri2779","article-title":"Phagocyte partnership during the onset and resolution of inflammation","volume":"10","author":"Soehnlein","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu Rev Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0952-7915(00)00241-7","article-title":"NK cells and NKT cells in innate defense against viral infections","volume":"13","author":"Biron","year":"2001","journal-title":"Curr Opin Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/1529-0131(200006)43:6<1204::AID-ANR3>3.0.CO;2-I","article-title":"Natural killer cells and natural killer T cells","volume":"43","author":"Seaman","year":"2000","journal-title":"Arthritis Rheum"},{"key":"B41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.0818-9641.2004.01261.x","article-title":"NKT cells and viral immunity","volume":"82","author":"Van Dommelen","year":"2004","journal-title":"Immunol Cell Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nri1199","article-title":"Roles of the NKG2D immunoreceptor and its ligands","volume":"3","author":"Raulet","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Annu Rev Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1390458","DOI":"10.1155\/2017\/1390458","article-title":"Deregulation of regulatory T cells in acute-on-chronic liver failure: a rat model","volume":"2017","author":"Ni","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B46","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10096-011-1291-1","article-title":"Peripheral T regulatory cells and cytokines in hepatitis E infection","volume":"31","author":"Tripathy","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1084\/jem.20030654","article-title":"CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo","volume":"198","author":"Oldenhove","year":"2003","journal-title":"J Exp Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 family members and inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection in transplant recipients","volume":"370","author":"Kamar","year":"2014","journal-title":"N Engl J Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/clinids\/12.6.1139","article-title":"Molecular mechanisms of action of ribavirin","volume":"12","author":"Patterson","year":"1990","journal-title":"Rev Infect Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/QCO.0000000000000316","article-title":"Treatment of hepatitis E virus","volume":"29","author":"Dalton","year":"2016","journal-title":"Curr Opin Infect Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1136\/gutjnl-2015-311000","article-title":"In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome","volume":"65","author":"Todt","year":"2016","journal-title":"Gut."},{"key":"B54","doi-asserted-by":"publisher","first-page":"7030","DOI":"10.3748\/wjg.v22.i31.7030","article-title":"Hepatitis E: discovery, global impact, control and cure","volume":"22","author":"Khuroo","year":"2016","journal-title":"World J Gastroenterol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1097\/00007890-199505270-00012","article-title":"Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients","volume":"59","author":"Rostaing","year":"1995","journal-title":"Transplantation."},{"key":"B56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1128\/AAC.01795-13","article-title":"Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon","volume":"58","author":"Debing","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.antiviral.2013.07.013","article-title":"Cutthroat trout virus as a surrogate in vitro infection model for testing inhibitors of hepatitis E virus replication","volume":"100","author":"Debing","year":"2013","journal-title":"Antiviral Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.antiviral.2013.12.005","article-title":"Antiviral strategies for hepatitis E virus","volume":"102","author":"Debing","year":"2014","journal-title":"Antiviral Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.micinf.2012.10.003","article-title":"Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle","volume":"15","author":"Murakami","year":"2013","journal-title":"Microbes Infect."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.725993\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T05:28:50Z","timestamp":1628486930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.725993\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":59,"alternative-id":["10.3389\/fmed.2021.725993"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.725993","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"article-number":"725993"}}